 international correspondent, covering pharma and regulatory issues around the word. He is also a political columnist for 

, one of the UK's leading regional business magazines. He started his career as a journalist at 

, the UK's Chinese community magazine, before joining the 

News

Pharmaceutical Executive-06-01-2001

Washington, DC-An FDA advisory committee voted overwhelmingly to recommend that Claritin (loratadine), Allegra (fexofenadine), and Zyrtec (cetirizine) be changed from prescription to over-the-counter products. Although the vote is not binding, FDA usually follows such panels’ recommendations.

Rx-to-OTC: Unwanted Attention

Kevin Gopal